Characteristics of HLA-A2–positive lymphoma cell lines
Cell line . | Histologic subtype . | PI-9 expression . | bcI-2 overexpression . | Sensitivity to Fas . | Sensitivity to TRAIL . |
|---|---|---|---|---|---|
| Granta-519 | Mantle cell lymphoma | + | + | Resistant | Low |
| JEKO-1 | Mantle cell lymphoma | - | - | Intermediate | Intermediate |
| DG-75 | Burkitt lymphoma | + | - | Resistant | Resistant |
| Loucy | T-ALL | - | + | Resistant | Low |
| Karpas-422 | B-DLCL | + | + | Low | Intermediate |
| SU-DHL-4 | B-DLCL | + | + | Resistant | High |
| SUP-M2 | Anaplastic large-cell lymphoma | - | - | Intermediate | Intermediate |
| Karpas-1106P | Mediastinal lymphoblastic B-NHL | - | - | Intermediate | Intermediate |
Cell line . | Histologic subtype . | PI-9 expression . | bcI-2 overexpression . | Sensitivity to Fas . | Sensitivity to TRAIL . |
|---|---|---|---|---|---|
| Granta-519 | Mantle cell lymphoma | + | + | Resistant | Low |
| JEKO-1 | Mantle cell lymphoma | - | - | Intermediate | Intermediate |
| DG-75 | Burkitt lymphoma | + | - | Resistant | Resistant |
| Loucy | T-ALL | - | + | Resistant | Low |
| Karpas-422 | B-DLCL | + | + | Low | Intermediate |
| SU-DHL-4 | B-DLCL | + | + | Resistant | High |
| SUP-M2 | Anaplastic large-cell lymphoma | - | - | Intermediate | Intermediate |
| Karpas-1106P | Mediastinal lymphoblastic B-NHL | - | - | Intermediate | Intermediate |